The LIMD2 Polyclonal Antibody (PACO10255) offered by AssayGenie is a powerful tool for researchers studying the LIMD2 protein, known for its role in cancer progression and metastasis. This antibody is raised in rabbits and has been rigorously validated for use in various applications, including Western blot and immunohistochemistry.LIMD2, also known as LIMD1-like protein, has been shown to be upregulated in various cancer types and is associated with poor prognosis. By specifically binding to the LIMD2 protein, this antibody enables precise detection and analysis in cancer cells and tissues, making it invaluable for studies in oncology and tumor biology.
The overexpression of LIMD2 has been linked to increased cell proliferation, migration, and invasion, highlighting its potential as a therapeutic target in cancer treatment. By investigating the function and regulation of LIMD2, researchers can gain insights into the mechanisms driving tumor growth and potentially identify novel strategies for cancer therapy.
